Sanofi India Ltd
Company Profile
Business description
Sanofi India Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It focuses on a range of therapeutic areas, including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines, among others, and sells its products through independent distributors predominantly in India. The company's products are manufactured in different types of dosage forms, including tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams, and ointments, and are marketed under different brand names such as Soframycin, Lantus, Cardace, Soliqua, Solian, Thyrogen, Telcite, Zolineg, etc. Geographically, the company generates a majority of its revenue from India, followed by Singapore, and other export markets.
Contact
Saki Vihar Road
Sanofi House, CTS Number 117-B
L&T Business Park
Powai
MumbaiMH400072
INDT: +91 2228032000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
1,285
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,520.20 | 9.50 | 0.11% |
CAC 40 | 7,823.79 | 50.04 | -0.64% |
DAX 40 | 23,501.47 | 137.09 | -0.58% |
Dow JONES (US) | 42,129.08 | 11.35 | -0.03% |
FTSE 100 | 8,572.77 | 30.15 | -0.35% |
HKSE | 23,640.65 | 532.38 | 2.30% |
NASDAQ | 19,114.42 | 104.33 | 0.55% |
Nikkei 225 | 38,128.13 | 55.13 | -0.14% |
NZX 50 Index | 12,779.26 | 7.48 | -0.06% |
S&P 500 | 5,892.10 | 5.55 | 0.09% |
S&P/ASX 200 | 8,279.60 | 10.60 | 0.13% |
SSE Composite Index | 3,403.95 | 29.08 | 0.86% |